To support U.S government and FDA in its fight against the novel coronavirus (COVID-19) , Global Regulatory Partners, Inc is offering its regulatory affairs services to support medical device and pharmaceutical companies that have products with the potential to diagnose, treat or prevent COVID-19. Global Regulatory Partners’ support includes:

  • Applications to FDA Emergency Use Authorization (EUA) for anti-COVID-19 products.
  • Organizing meeting with BARDA to discuss possible financing of research and development of anti-COVID-19 products.
  • Communication with FDA regarding anti-COVID-19 products.
  • Defining the right regulatory strategy for the registration of new anti-Covid-19 products with FDA.

How to Register for Emergency Use Authorization (EUA)

Global Regulatory Partners is Supporting the Fight Against Coronavirus (COVID-19) -Contact Us to Learn More

About Global Regulatory Partners:

Global Regulatory Partners Inc, (GRP) is an American company that provides regulatory affairs, clinical, quality and safety services to medical devices and pharmaceutical companies globally. GRP headquarters is located in Massachusetts USA and its main affiliates are located in China, Japan, Brazil, Mexico and Argentina. GRP helps many life science companies register their products in different countries in compliance with local regulations.

Share This Post: